1. Home
  2. ARLO vs TYRA Comparison

ARLO vs TYRA Comparison

Compare ARLO & TYRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arlo Technologies Inc.

ARLO

Arlo Technologies Inc.

HOLD

Current Price

$13.33

Market Cap

1.6B

ML Signal

HOLD

Logo Tyra Biosciences Inc.

TYRA

Tyra Biosciences Inc.

HOLD

Current Price

$25.65

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARLO
TYRA
Founded
2018
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Consumer Electronics/Appliances
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.3B
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
ARLO
TYRA
Price
$13.33
$25.65
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
11
Target Price
$24.00
$47.50
AVG Volume (30 Days)
1.1M
1.1M
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
145.16
N/A
EPS
0.16
N/A
Revenue
N/A
N/A
Revenue This Year
$9.29
N/A
Revenue Next Year
$8.82
N/A
P/E Ratio
$82.66
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.05
$12.40
52 Week High
$19.94
$40.65

Technical Indicators

Market Signals
Indicator
ARLO
TYRA
Relative Strength Index (RSI) 48.51 49.78
Support Level $12.35 $23.99
Resistance Level $14.06 $27.87
Average True Range (ATR) 0.59 2.14
MACD 0.02 0.24
Stochastic Oscillator 48.50 64.22

Price Performance

Historical Comparison
ARLO
TYRA

About ARLO Arlo Technologies Inc.

Arlo Technologies Inc is engaged in the provision of security and video monitoring solutions for homes and businesses. Its cloud-based platform provides users with visibility, insight, and a powerful means to help protect and connect in real-time with the people and things that matter, from any location with a Wi-Fi or cellular connection. The company offers subscription services such as Arlo Secure, Arlo Total Security, and Arlo Safe, and several categories of smart security devices, including smart Wi-Fi and LTE-enabled cameras, video doorbells, floodlight cameras, and home security systems. Geographically, the company generates a majority of its revenue from the United States, followed by Spain, Sweden, and other countries.

About TYRA Tyra Biosciences Inc.

Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines for large opportunities in targeted oncology and genetically defined conditions, harnessing the power of Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are FGFR3, FGFR4/3, and FGFR1/2/3: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.

Share on Social Networks: